VIRX

Viracta Therapeutics, Inc. Common Stock

Delisted

VIRX was delisted on the 3rd of February, 2025.

75 hedge funds and large institutions have $180M invested in Viracta Therapeutics, Inc. Common Stock in 2013 Q2 according to their latest regulatory filings, with 75 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
75
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$209K
Puts
$2.58M
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
51
$169K
52
$154K
53
$152K
54
$149K
55
$147K
56
$122K
57
$116K
58
$114K
59
$108K
60
$105K
61
$101K
62
$100K
63
$95K
64
$84K
65
$81K
66
$78K
67
$63.7K
68
$55K
69
$52K
70
$39K
71
$30K
72
$19K
73
$5K
74
$5K
75
$5K